BioCentury | Sep 3, 2019
Clinical News

Sept. 3 Clinical Quick Takes: Phase II failure for Aridis, plus Kura, Idorsia, Concert, PegBio

...aeruginosa and focus on its remaining pipeline, which includes lead candidate AR-301, a mAb against aHL...
...of GCGR and GLP-1R, which is administered in once-weekly doses, will improve patient compliance. Targets: aHL...
...Inc. Idorsia Ltd. Kura Oncology Inc. PegBio Co. Ltd. Glucagon receptor (GCGR) Glucagon-like peptide-1 receptor (GLP-1R) (GLP1R) Janus kinase (JAK) S. aureus alpha-hemolysin (aHL) Pneumonia Bladder...
BioCentury | Aug 17, 2018
Financial News

Infectious company Aridis raises $26M in NASDAQ IPO

...U.S. and Orphan Drug designation in Europe, is a human IgG1 mAb against S. aureus alpha-hemolysin (aHL)...
BioCentury | Aug 10, 2018
Financial News

Aridis amends IPO

...pneumonia (HAP) and ventilator-associated pneumonia (VAP). Salvecin is a human IgG1 mAb against Staphylococcus aureus alpha-hemolysin (aHL)...
BioCentury | Jul 20, 2018
Financial News

Aridis proposes $34.5M IPO

...The company's lead candidate Salvecin (AR-301, tosatoxumab) is a human IgG1 mAb against Staphylococcus aureus alpha-hemolysin (aHL)...
...designation in Europe. Aridis Pharmaceuticals Inc., San Jose, Calif. Brian Moy Salvecin (AR-301, kbsa301) Aridis Pharmaceuticals Inc. S. aureus alpha-hemolysin (aHL)...
BioCentury | Jun 29, 2018
Clinical News

Arsanis discontinues Phase II of lead anti-infective

...ventilated patients. ASN100 combines two mAbs that neutralize S. aureus toxins. ASN-1 targets S. aureus alpha-hemolysin (aHL)...
...RSV infection. Arsanis Inc. (NASDAQ:ASNS), Waltham, Mass. Product: ASN100 Business: Infectious Molecular target: S. aureus alpha-hemolysin (aHL)...
BioCentury | Jun 28, 2018
Clinical News

Arsanis discontinues Phase II of lead anti-infective, shares plummet

...ventilated patients. ASN100 combines two mAbs that neutralize S. aureus toxins. ASN-1 targets S. aureus alpha-hemolysin (aHL)...
BioCentury | May 25, 2018
Preclinical News

Monitoring the gut with engineered biosensor

...data to a laptop computer and phone. The paper also showed thiosulfate and acyl-homoserine lactone (AHL...
BioCentury | Mar 9, 2018
Company News

Aridis, Shenzhen Hepalink form China JV

...The company did not provide details. Salvecin is a human IgG1 mAb against Staphylococcus aureus alpha-hemolysin (aHL)...
BioCentury | Feb 14, 2018
Translation in Brief

Poring over pain

...cationic lidocaine derivative QX-314.” Journal of Neurophysiology (2013) Winnie Pong, Staff Writer Harvard Medical School N-formyl-methionyl-isoleucyl-phenylalanine-leucine (fMIFL) S. aureus alpha-hemolysin (aHL) S...
BioCentury | Nov 30, 2017
Emerging Company Profile

A versatile sponge

...Calif. Critical Pressure Ltd., Cambridge, U.K. University of California San Diego, La Jolla, Calif. Targets aHL...
Items per page:
1 - 10 of 27